(F538)野村全球生技醫療基金
依持有類股(資料日期:2026/01/23)
依產業(資料日期:2025/12/31)
依區域(資料日期:2025/12/31)
持股明細(資料日期:2025/12/31)
持股名稱比例
ELI LILLY & CO7.54%
GILEAD SCIENCES INC6.90%
AMGEN INC6.63%
VERTEX PHARMACEUTICALS INC6.40%
Astrazeneca Plc5.98%
ALNYLAM PHARMACEUTICALS INC5.95%
NEUROCRINE BIOSCIENCES INC4.92%
ABBVIE INC4.89%
State Street SPDR標普生技ETF4.17%
REGENERON PHARMACEUTICALS3.82%
ARGENX SE - ADR3.66%
INCYTE CORP3.40%
BOSTON SCIENTIFIC2.87%
Mckesson Corp2.83%
ROCHE HOLDING AG-GENUSSCHEIN2.62%
LONZA GROUP AG-REG2.54%
DAIICHI SANKYO CO LTD2.06%
BIOGEN INC2.01%
ROYALTY PHARMA PLC- CL A1.80%
HANSOH PHARMACEUTICAL GROUP1.75%
iShares生技ETF1.68%
NOVARTIS AG-REG1.60%
AMNEAL PHARMACEUTICALS INC1.40%
TEMPUS AI INC1.17%
MERCK & CO. INC.1.10%
State Street SPDR健康照護精選行業ETF1.02%
Johnson & Johnson1.01%
投資注意事項